Phase III multicentric study evaluating the efficacy and safety of sirolimus in Vascular Anomalies that are refractory to standard care

Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2015
This article has no abstract
Epistemonikos ID: 2cfcd14187887837a8cb5179e0a7c90935fa8705
First added on: Jul 27, 2021